These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 25406147

  • 1. Intensity and quality of warfarin anticoagulation in Chinese patients: setting the record straight.
    Eikelboom JW, Hart RG.
    Stroke; 2015 Jan; 46(1):5-6. PubMed ID: 25406147
    [No Abstract] [Full Text] [Related]

  • 2. Response to letter regarding article, "Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control".
    Chan PH, Hai JJ, Siu CW.
    Stroke; 2015 Mar; 46(3):e72. PubMed ID: 25649808
    [No Abstract] [Full Text] [Related]

  • 3. Letter by Feng et al regarding article, "Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control".
    Feng X, Huan Y, Lv Y.
    Stroke; 2015 Mar; 46(3):e71. PubMed ID: 25649800
    [No Abstract] [Full Text] [Related]

  • 4. Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control.
    Ho CW, Ho MH, Chan PH, Hai JJ, Cheung E, Yeung CY, Lau KK, Chan KH, Lau CP, Lip GY, Leung GK, Tse HF, Siu CW.
    Stroke; 2015 Jan; 46(1):23-30. PubMed ID: 25406148
    [Abstract] [Full Text] [Related]

  • 5. [Comparison of three methods of antithrombotic therapy in elderly patients with nonvalvular atrial fibrillation].
    Shevelev VI, Kanorskiĭ SG.
    Kardiologiia; 2012 Jan; 52(7):56-60. PubMed ID: 22839715
    [Abstract] [Full Text] [Related]

  • 6. Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial.
    Hart RG, Diener HC, Yang S, Connolly SJ, Wallentin L, Reilly PA, Ezekowitz MD, Yusuf S.
    Stroke; 2012 Jun; 43(6):1511-7. PubMed ID: 22492518
    [Abstract] [Full Text] [Related]

  • 7. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
    Freeman JV, Zhu RP, Owens DK, Garber AM, Hutton DW, Go AS, Wang PJ, Turakhia MP.
    Ann Intern Med; 2011 Jan 04; 154(1):1-11. PubMed ID: 21041570
    [Abstract] [Full Text] [Related]

  • 8. Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.
    Graham DJ, Reichman ME, Wernecke M, Zhang R, Southworth MR, Levenson M, Sheu TC, Mott K, Goulding MR, Houstoun M, MaCurdy TE, Worrall C, Kelman JA.
    Circulation; 2015 Jan 13; 131(2):157-64. PubMed ID: 25359164
    [Abstract] [Full Text] [Related]

  • 9. Intracranial hemorrhage mortality in atrial fibrillation patients treated with dabigatran or warfarin.
    Alonso A, Bengtson LG, MacLehose RF, Lutsey PL, Chen LY, Lakshminarayan K.
    Stroke; 2014 Aug 13; 45(8):2286-91. PubMed ID: 24994722
    [Abstract] [Full Text] [Related]

  • 10. Dabigatran for stroke prevention in all patients with atrial fibrillation?
    Hunchuck JE, Lake JD.
    Pharmacotherapy; 2011 Aug 13; 31(8):725-8. PubMed ID: 21923597
    [No Abstract] [Full Text] [Related]

  • 11. Bleeding rates in Veterans Affairs patients with atrial fibrillation who switch from warfarin to dabigatran.
    Vaughan Sarrazin MS, Jones M, Mazur A, Chrischilles E, Cram P.
    Am J Med; 2014 Dec 13; 127(12):1179-85. PubMed ID: 25107386
    [Abstract] [Full Text] [Related]

  • 12. The importance of postapproval data for dabigatran.
    Redberg RF.
    JAMA Intern Med; 2015 Jan 13; 175(1):25. PubMed ID: 25365377
    [No Abstract] [Full Text] [Related]

  • 13. Dabigatran efficacy-safety assessment for stroke prevention in patients with atrial fibrillation.
    Eikelboom JW, Quinlan DJ, Connolly SJ, Hart RG, Yusuf S.
    J Thromb Haemost; 2012 May 13; 10(5):966-8. PubMed ID: 22360879
    [No Abstract] [Full Text] [Related]

  • 14. The use of dabigatran immediately after atrial fibrillation ablation.
    Winkle RA, Mead RH, Engel G, Kong MH, Patrawala RA.
    J Cardiovasc Electrophysiol; 2012 Mar 13; 23(3):264-8. PubMed ID: 21955008
    [Abstract] [Full Text] [Related]

  • 15. Safety of novel oral anticoagulants compared with uninterrupted warfarin for catheter ablation of atrial fibrillation.
    Armbruster HL, Lindsley JP, Moranville MP, Habibi M, Khurram IM, Spragg DD, Berger RD, Calkins H, Marine JE.
    Ann Pharmacother; 2015 Mar 13; 49(3):278-84. PubMed ID: 25515868
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion.
    Nagarakanti R, Ezekowitz MD, Oldgren J, Yang S, Chernick M, Aikens TH, Flaker G, Brugada J, Kamensky G, Parekh A, Reilly PA, Yusuf S, Connolly SJ.
    Circulation; 2011 Jan 18; 123(2):131-6. PubMed ID: 21200007
    [Abstract] [Full Text] [Related]

  • 18. Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin.
    Zalesak M, Siu K, Francis K, Yu C, Alvrtsyan H, Rao Y, Walker D, Sander S, Miyasato G, Matchar D, Sanchez H.
    Circ Cardiovasc Qual Outcomes; 2013 Sep 01; 6(5):567-74. PubMed ID: 23922182
    [Abstract] [Full Text] [Related]

  • 19. [Safety and efficacy of various modalities of antiplatelet prophylaxis of ischemic stroke in elderly patients with non-valvular atrial fibrillation].
    Shevelev VI, Kanorsky SG.
    Klin Med (Mosk); 2012 Sep 01; 90(10):60-3. PubMed ID: 23285766
    [Abstract] [Full Text] [Related]

  • 20. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
    Cairns JA, Connolly S, McMurtry S, Stephenson M, Talajic M, CCS Atrial Fibrillation Guidelines Committee.
    Can J Cardiol; 2011 Sep 01; 27(1):74-90. PubMed ID: 21329865
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.